tradingkey.logo
tradingkey.logo
Search

Monopar Therapeutics Inc

MNPR
Add to Watchlist
110.450USD
+0.580+0.53%
Close 07-27 16:00ETQuotes delayed by 15 min
739.91MMarket Cap
LossP/E TTM

MNPR Financials

See Monopar Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Monopar Therapeutics Inc Earnings Date

Latest Release
May 14, 2026
EPS / Forecast
-0.46/-0.84
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-1.85
54.99%
Analyst Rating
BUY
2026/07/27
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-21.41%-0.46
72.65%-0.61
-30.25%-0.48
28.41%-0.35
26.85%-0.38
-259.71%-2.23
46.45%-0.37
40.25%-0.49
44.71%-0.51
44.90%-0.62
---0.69
---0.82
---0.93
---1.12
---3.01
----
----
----
----
----
Net Profit
-48.31%-3.89M
52.40%-5.20M
-163.56%-3.44M
-43.04%-2.45M
-59.94%-2.62M
-502.32%-10.93M
33.24%-1.30M
22.03%-1.72M
32.59%-1.64M
37.37%-1.81M
18.58%-1.95M
20.37%-2.20M
0.90%-2.43M
-8.05%-2.90M
2.39%-2.40M
-32.82%-2.76M
-30.40%-2.46M
-25.94%-2.68M
-49.96%-2.46M
-43.88%-2.08M
Operating profit
-62.18%-5.23M
44.42%-6.16M
-159.89%-4.09M
-80.81%-3.23M
-86.95%-3.22M
-479.22%-11.07M
23.77%-1.57M
23.17%-1.79M
31.75%-1.72M
34.33%-1.91M
14.18%-2.07M
15.75%-2.33M
-2.76%-2.53M
-8.60%-2.91M
2.10%-2.41M
-32.07%-2.76M
-29.69%-2.46M
-18.59%-2.68M
-49.21%-2.46M
-42.91%-2.09M
Net Profit
-48.31%-3.89M
52.40%-5.20M
-163.56%-3.44M
-43.04%-2.45M
-59.94%-2.62M
-502.32%-10.93M
33.24%-1.30M
22.03%-1.72M
32.59%-1.64M
37.37%-1.81M
18.58%-1.95M
20.37%-2.20M
0.90%-2.43M
-8.05%-2.90M
2.39%-2.40M
-32.82%-2.76M
-30.40%-2.46M
-25.94%-2.68M
-49.96%-2.46M
-43.88%-2.08M
Current assets
150.10%137.74M
132.97%140.46M
2273.95%144.09M
648.60%53.75M
517.98%55.08M
722.24%60.29M
-29.16%6.07M
-30.30%7.18M
-24.36%8.91M
-44.31%7.33M
-40.38%8.57M
-38.14%10.30M
-34.58%11.78M
-35.84%13.17M
-35.98%14.37M
-31.72%16.65M
-30.29%18.01M
22.15%20.52M
24.11%22.45M
91.59%24.39M
Total current liabilities
64.73%2.46M
-47.94%2.74M
128.75%2.57M
45.36%1.58M
3.96%1.49M
198.98%5.25M
-43.34%1.12M
-56.45%1.09M
-50.30%1.44M
-43.83%1.76M
3.53%1.98M
14.40%2.50M
168.85%2.89M
97.96%3.13M
54.39%1.91M
98.16%2.19M
33.22%1.07M
34.32%1.58M
103.32%1.24M
92.56%1.10M
Total assets
150.49%137.98M
133.40%140.72M
2275.71%144.20M
650.24%53.87M
518.08%55.09M
720.83%60.29M
-29.37%6.07M
-30.55%7.18M
-24.68%8.91M
-44.47%7.35M
-40.51%8.59M
-38.23%10.34M
-34.51%11.83M
-35.55%13.23M
-35.85%14.45M
-31.57%16.74M
-30.26%18.07M
21.66%20.52M
24.02%22.52M
91.03%24.46M
Total liabilities
73.55%2.59M
-44.99%2.89M
135.06%2.64M
52.73%1.66M
3.96%1.49M
198.98%5.25M
-43.34%1.12M
-56.45%1.09M
-50.30%1.44M
-43.98%1.76M
2.41%1.98M
12.69%2.50M
162.65%2.89M
98.50%3.14M
56.07%1.94M
101.16%2.22M
36.36%1.10M
34.32%1.58M
86.61%1.24M
70.28%1.10M
Total equity
152.63%135.39M
150.43%137.83M
2761.61%141.56M
757.13%52.20M
616.76%53.59M
884.95%55.04M
-25.18%4.95M
-22.29%6.09M
-16.41%7.48M
-44.62%5.59M
-47.15%6.61M
-46.02%7.84M
-47.28%8.94M
-46.73%10.09M
-41.21%12.51M
-37.84%14.52M
-32.40%16.97M
20.71%18.94M
21.64%21.28M
92.14%23.35M
Net operating income
38.66%-3.47M
-68.64%-3.37M
-94.74%-2.09M
35.75%-1.08M
-242.11%-5.66M
-29.27%-2.00M
44.66%-1.07M
20.21%-1.68M
27.11%-1.66M
-18.75%-1.55M
9.71%-1.94M
-60.32%-2.10M
7.96%-2.27M
35.93%-1.30M
-10.67%-2.15M
6.78%-1.31M
-27.32%-2.47M
-63.77%-2.03M
-49.27%-1.94M
-41.25%-1.41M
Net investment
-1613.65%-5.58M
-333.72%-62.19M
-315.68%-2.13M
49100.99%1.19M
66.86%-325.83K
-582.70%-14.34M
7652.33%985.73K
-100.08%-2.42K
0.01%-983.31K
160.39%2.97M
---13.05K
--2.95M
---983.44K
---4.92M
----
----
----
----
----
----
Net financing
-73.06%-200.20K
-100.69%-384.68K
558897.68%92.39M
-3094.32%-316.85K
-103.64%-115.68K
16679.90%56.14M
-106.70%-16.53K
-101.55%-9.92K
295.36%3.18M
141.14%334.55K
1139.27%246.70K
1079.50%641.18K
4928.98%804.80K
1885.09%138.74K
-137.90%-23.74K
-172.72%-65.46K
-100.15%-16.67K
-8.85%-7.77K
-100.15%-9.98K
-102.54%-24.00K

FAQs

What are the current assets of Monopar Therapeutics Inc?

According to Monopar Therapeutics Inc's FY2025 earnings report, its current assets were 140.46M, with a year-on-year change of 132.97.

What are the total assets of Monopar Therapeutics Inc?

According to Monopar Therapeutics Inc's FY2025 earnings report, its total assets of Monopar Therapeutics Inc were 140.72M, with a year-on-year change of 133.40.

What are the total liabilities of Monopar Therapeutics Inc?

According to Monopar Therapeutics Inc's FY2025 earnings report, its total liabilities of Monopar Therapeutics Inc were 2.89M, with a year-on-year change of -44.99.

What is the total equity of Monopar Therapeutics Inc?

According to Monopar Therapeutics Inc's FY2025 earnings report, its total equity of Monopar Therapeutics Inc was 137.83M, with a year-on-year change of 150.43.

What is the net operating income of Monopar Therapeutics Inc?

According to Monopar Therapeutics Inc's FY2025 earnings report, its net operating income of Monopar Therapeutics Inc was -16.70M, with a year-on-year change of -3.36.

What is the net investment of Monopar Therapeutics Inc?

According to Monopar Therapeutics Inc's FY2025 earnings report, its net investment of Monopar Therapeutics Inc was -63.45M, with a year-on-year change of -342.54.

What is the net financing of Monopar Therapeutics Inc?

According to Monopar Therapeutics Inc's FY2025 earnings report, its net financing of Monopar Therapeutics Inc was 91.57M, with a year-on-year change of 54.45.

What is the Earnings Per Share (EPS) of Monopar Therapeutics Inc?

According to Monopar Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.85, with a year-on-year change of 54.99.

What is the net income of Monopar Therapeutics Inc?

According to Monopar Therapeutics Inc's FY2025 earnings report, its net income was -13.72M, with a year-on-year change of 11.99.

What is the Return on Equity (ROE) of Monopar Therapeutics Inc?

According to Monopar Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -14.22, with a year-on-year change of 72.34.

What is the Return on Assets (ROA) of Monopar Therapeutics Inc?

According to Monopar Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -13.65, with a year-on-year change of 70.39.

What is the operating profit of Monopar Therapeutics Inc?

According to Monopar Therapeutics Inc's FY2025 earnings report, its operating profit was -16.70M, with a year-on-year change of -3.36.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.